Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir
- 21 March 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 20 (5), 783-784
- https://doi.org/10.1097/01.aids.0000216384.22432.9a
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addictionAIDS, 2005
- ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRODrug Metabolism and Disposition, 2005
- Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trialAIDS, 2003
- AtazanavirDrugs, 2003
- Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomesLife Sciences, 1997
- Drug Interactions in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- The Glucuronidation of Exogenous and Endogenous Compounds by Stably Expressed Rat and Human UDP-Glucuronosyltransferase 1.1Archives of Biochemistry and Biophysics, 1996